Adalimumab
| Use attributes for filter ! | |
| CAS ID | 331731-18-1 |
|---|---|
| Formula | C6428H9912N1694O1987S46 |
| Molar mass | 144190. 3 g·mol−1 |
| Drug class | TNF inhibitor |
| Trade name | Humira, Mabura, Exemptia, others |
| Target | TNF alpha |
| Other names | adalimumab-adaz, adalimumab-adbm, adalimumab-afzb, adalimumab-atto, adalimumab-bwwd |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951133 |
About Adalimumab
Adalimumab, sold under the brand name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.